Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EGFR | P00533 | 15/20 | 1.00 |
| ▸ | ERBB2 | P04626 | 6/20 | 0.72 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.66 |
| ▸ | HTT | P42858 | 2/20 | 0.62 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.62 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.57 |
| ▸ | CD38 | P28907 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13755816 | 1.00 | EGFR (1.00) | EGFRERBB2MAPK1HTTHIF1A | |
| SCHEMBL8872089 | 0.84 | EGFR (1.00) | EGFRERBB2MAPK1HTTHIF1A | |
| SCHEMBL8871863 | 0.83 | EGFR (0.82) | EGFRERBB2MAPK1HTTHIF1A | |
| SCHEMBL159209 | 0.80 | EGFR (1.00) | EGFRERBB2MAPK1HTTHIF1A | |
| SCHEMBL4349199 | 0.80 | MAPK1 (1.00) | EGFRERBB2MAPK1HTTHIF1A | |
| SCHEMBL29350058 | 0.80 | EGFR (1.00) | EGFRERBB2MAPK1HTTHIF1A | |
| Hydrochloric Acid SCHEMBL6186081 | 0.79 | MAPK1 (0.97) | EGFRERBB2MAPK1HTTHIF1A | |
| SCHEMBL11087835 | 0.79 | EGFR (0.80) | EGFRERBB2MAPK1HTTHIF1A | |
| SCHEMBL9215676 | 0.79 | EGFR (0.74) | EGFRERBB2MAPK1HTTHIF1A | |
| SCHEMBL8427296 | 0.79 | EGFR (0.74) | EGFRERBB2MAPK1HTTHIF1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250354152-A1 | PHARMACEUTICAL COMPOUND FOR PREVENTION OR TREATMENT OF LIVER FIBROSIS | MEDIZINISCHE HOCHSCULE HANNOVER (DE) | 2025-11-20 | — | — | US | disclosed |
| EP-4536826-A1 | PHARMACEUTICAL COMPOUND FOR PREVENTION OR TREATMENT OF LIVER FIBROSIS | Medizinische Hochschule Hannover (DE) | 2025-04-16 | — | — | EP | disclosed |
| WO-2023237630-A1 | PHARMACEUTICAL COMPOUND FOR PREVENTION OR TREATMENT OF LIVER FIBROSIS | MEDIZINISCHE HOCHSCHULE HANNOVER (DE) | 2023-12-14 | — | — | WO | disclosed |
| EP-4289436-A1 | PHARMACEUTICAL COMPOUND FOR PREVENTION OR TREATMENT OF LIVER FIBROSIS | Medizinische Hochschule Hannover (DE) | 2023-12-13 | — | — | EP | disclosed |